TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name |
City of registered office |
Country of registered office |
J.P. Morgan Securities plc |
|
|
5. Date on which the threshold was crossed or reached
05-Sep-2023
6. Date on which Issuer notified
07-Sep-2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
Resulting situation on the date on which threshold was crossed or reached |
2.863058 |
5.520916 |
8.383974 |
9550712 |
Position of previous notification (if applicable) |
3.496071 |
5.532998 |
9.029069 |
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
GB0009633180 |
|
3262993 |
|
2.863058 |
Sub Total 8.A |
3262993 |
2.863058% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
Sub Total 8.B1 |
|
|
|
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
Cash-settled Equity Swap |
03/10/2023 |
03/10/2023 |
Cash |
17 |
0.000014 |
Cash-settled Equity Swap |
12/12/2023 |
12/12/2023 |
Cash |
2003204 |
1.758919 |
Cash-settled Equity Swap |
20/02/2024 |
20/02/2024 |
Cash |
6220 |
0.005452 |
Cash-settled Equity Swap |
04/03/2024 |
04/03/2024 |
Cash |
5090 |
0.004469 |
Cash-settled Equity Swap |
19/06/2024 |
19/06/2024 |
Cash |
3386 |
0.002972 |
Cash-settled Equity Swap |
27/06/2024 |
27/06/2024 |
Cash |
2761 |
0.002424 |
Cash-settled Equity Swap |
02/07/2024 |
02/07/2024 |
Cash |
3066 |
0.002687 |
Cash-settled Equity Swap |
12/07/2024 |
12/07/2024 |
Cash |
1390089 |
1.220572 |
Cash-settled Equity Swap |
31/07/2024 |
31/07/2024 |
Cash |
39012 |
0.034252 |
Cash-settled Equity Swap |
02/08/2024 |
02/08/2024 |
Cash |
531 |
0.000463 |
Cash-settled Equity Swap |
18/09/2024 |
18/09/2024 |
Cash |
2288 |
0.002008 |
Cash-settled Equity Swap |
16/01/2026 |
16/01/2026 |
Cash |
420 |
0.000368 |
Cash-settled Equity Swap |
18/06/2027 |
18/06/2027 |
Cash |
6891 |
0.006050 |
Cash-settled Equity Swap |
28/06/2030 |
28/06/2030 |
Cash |
2520 |
0.002212 |
Cash-settled Equity Swap |
17/10/2024 |
17/10/2024 |
Cash |
196288 |
0.172351 |
Cash-settled Equity Swap |
21/02/2024 |
21/02/2024 |
Cash |
1189996 |
1.044879 |
Cash-settled Equity Swap |
30/05/2028 |
30/05/2028 |
Cash |
10285 |
0.009030 |
Cash-settled Equity Swap |
02/10/2024 |
02/10/2024 |
Cash |
361 |
0.000316 |
Cash-settled Equity Swap |
08/10/2024 |
08/10/2024 |
Cash |
229 |
0.000199 |
Cash-settled Equity Swap |
06/03/2024 |
06/03/2024 |
Cash |
1420344 |
1.247137 |
Cash-settled Equity Swap |
03/10/2024 |
03/10/2024 |
Cash |
792 |
0.000693 |
Cash-settled Equity Swap |
05/09/2024 |
05/09/2024 |
Cash |
3929 |
0.003449 |
Sub Total 8.B2 |
|
6287719 |
5.520916% |
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
JPMorgan Chase & Co. |
J.P. Morgan Securities plc |
2.856851 |
5.520916 |
8.377767% |
JPMorgan Chase & Co. |
J.P. Morgan Securities LLC |
|
|
|
JPMorgan Chase & Co. |
J.P. Morgan SE |
|
|
|
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
12. Date of Completion
07-Sep-2023
13. Place Of Completion
London, United Kingdom